LABORATORIOS BIOPAS S.A.
Import activity
2017 to 2026Is LABORATORIOS BIOPAS S.A on a US restricted-party list?
Checked against 13 Commerce, State and Treasury lists, refreshed daily.
What LABORATORIOS BIOPAS S.A imports
share of the ranked product mix| HS code | Product | Share | Ranked |
|---|---|---|---|
| 3004902900 | Medicaments, consisting of mixed or unmixed products in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | 31.3% | #1 · 10 yrs |
| 3002159000 | Blood, human or animal, antisera, other blood fractions and immunological products, immunological products, put up in measured doses or in forms or packings for retail sale | 28.7% | #1 · 10 yrs |
| 3004391900 | Medicaments, containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | 13.3% | #3 · 10 yrs |
| 3002909000 | Toxins, cultures of micro-organisms (excluding yeasts) and similar products | 10.0% | #3 · 5 yrs |
| 3002499000 | Toxins, cultures of micro-organisms (excluding yeasts) and similar products, in item 3002.3 | 7.3% | #3 · 5 yrs |
| 3004501000 | Medicaments, containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | 6.7% | #4 · 7 yrs |
| 3002122900 | Blood, human or animal, antisera, other blood fractions and immunological products, antisera and other blood fractions | 1.3% | #4 · 2017 |
| 3002151000 | Blood, human or animal, antisera, other blood fractions and immunological products, immunological products, put up in measured doses or in forms or packings for retail sale | 1.3% | #5 · 2 yrs |
Share folds the directory's yearly top-five ranks across every year on record (a #1 counts five times a #5); the source publishes ranks, not per-product volumes.
Largest importers of medicaments
ranked by declared CIF, all years| # | Company | Active | Products | Declarations | Declared value |
|---|---|---|---|---|---|
| 1 | BAYER S.A. | 10 yr | 5 | 1,543 | $265.4M |
| 2 | PRODUCTOS ROCHE S.A. | 10 yr | 5 | 7,429 | $255.6M |
| 3 | BOEHRINGER INGELHEIM S.A. | 10 yr | 5 | 737 | $237.5M |
| 4 | ASTRAZENECA COLOMBIA S.A.S. | 10 yr | 5 | 269 | $232.9M |
| 5 | MERCK SHARP & DOHME COLOMBIA S.A.S. | 10 yr | 5 | 5,892 | $219.2M |
| 6 | PROCTER & GAMBLE COLOMBIA LTDA | 9 yr | 5 | 4,187 | $203.2M |
| 7 | PFIZER S A S | 10 yr | 5 | 386 | $178.6M |
| 8 | NOVARTIS DE COLOMBIA S.A. | 10 yr | 5 | 1,292 | $176.1M |
| 9 | NOVONORDISKCOLOMBIAS.A.S | 10 yr | 5 | 534 | $154.7M |
| 10 | SANOFI-AVENTIS DE COLOMBIA S.A. | 10 yr | 5 | 354 | $153.4M |
| 17 | LABORATORIOS BIOPAS S.A. | 10 yr | 5 | 327 | $70.2M |
Who supplies LABORATORIOS BIOPAS S.A?
Look up the exporters shipping to LABORATORIOS BIOPAS S.A, with what they ship and how, in the app.
Decision makers at LABORATORIOS BIOPAS S.A
Purchasing, import and management contacts with titles and LinkedIn profiles, revealed in the platform.
Unit prices, the complete declaration history, the LinkedIn decision-maker finder and the AI Analyst for LABORATORIOS BIOPAS S.A.
Common questions
What does LABORATORIOS BIOPAS S.A import?
Colombia's customs importer directory (DIAN) list medicaments, blood and toxins, cultures of micro-organisms as LABORATORIOS BIOPAS S.A's principal imports (ranked by HS subheading, 8 products on record).
How much does LABORATORIOS BIOPAS S.A import?
$70.2M of declared CIF value in 2025 across 327 import declarations (-5% versus 2024); $530.1M in total between 2017 to 2026.
Where does LABORATORIOS BIOPAS S.A source from?
Colombia's importer directory publishes each importer's products, declared value, net weight and declaration count, but not its origin countries or suppliers.
Who else imports medicaments in Colombia?
BAYER S.A., PRODUCTOS ROCHE S.A. and BOEHRINGER INGELHEIM S.A. rank among the largest importers of medicaments (HS 3004) in Colombia, out of 276 importers on record in 2025.
Where does this data come from?
Directly from Colombia's customs importer directory (DIAN). Exsigo ingests the official records; nothing here is scraped from directories or estimated.